NO940589L - Transdermal medikamentavleveringsinnretning som anvender en membranbeskyttet mikroporös membran for å oppnå forsinket begynnelse - Google Patents
Transdermal medikamentavleveringsinnretning som anvender en membranbeskyttet mikroporös membran for å oppnå forsinket begynnelseInfo
- Publication number
- NO940589L NO940589L NO940589A NO940589A NO940589L NO 940589 L NO940589 L NO 940589L NO 940589 A NO940589 A NO 940589A NO 940589 A NO940589 A NO 940589A NO 940589 L NO940589 L NO 940589L
- Authority
- NO
- Norway
- Prior art keywords
- membrane
- drug
- permeable
- delivery device
- microporous membrane
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Transdermal medikamentavleverlngsinnretningmed forsinket begynnelse har en forslnkelsesperlode på minst åtte timer og omfatter en laminert komposltt av (1) et toppbaklag; (2) et trykkbrytbart lag som ligger under (1); (3) et reservoar av en oppløsning av medikament l en flytende bærer (1) og (2); (4) et flettet lag som ligger under (2) for dlspergerlng av medikament med en gang (2) er oppbrudt; (5) et første adheslvt lag som ligger under (4) som er permeabel for medlkamentet; (6) en første polymermembran som er permeabel for medlkamentet men hovedsakelig impermeabel for adheslvet l (5); (7) en mikroporøs membran som ligger under (6) som selv er impermeabel for medi- kamentet og hvis porer er ufylte; (8) en annen polymermembran som ligger under den mikroporøse membranen som er permeabel for medikament men hoved- sakelig impermeabel for adhesiv i (9) under; og (9) et annet adheslvt lag som ligger under (8) som er permeabel for medlkamentet.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/748,935 US5273756A (en) | 1991-08-23 | 1991-08-23 | Transdermal drug delivery device using a membrane-protected microporous membrane to achieve delayed onset |
PCT/US1992/006839 WO1993003692A1 (en) | 1991-08-23 | 1992-08-14 | Transdermal drug delivery device using a membrane-protected microporous membrane to achieve delayed onset |
Publications (2)
Publication Number | Publication Date |
---|---|
NO940589D0 NO940589D0 (no) | 1994-02-21 |
NO940589L true NO940589L (no) | 1994-04-13 |
Family
ID=25011540
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO940589A NO940589L (no) | 1991-08-23 | 1994-02-21 | Transdermal medikamentavleveringsinnretning som anvender en membranbeskyttet mikroporös membran for å oppnå forsinket begynnelse |
Country Status (10)
Country | Link |
---|---|
US (1) | US5273756A (no) |
EP (1) | EP0600023A4 (no) |
JP (1) | JPH06510043A (no) |
AU (1) | AU670410B2 (no) |
CA (1) | CA2115570A1 (no) |
FI (1) | FI940850A (no) |
NO (1) | NO940589L (no) |
NZ (1) | NZ244000A (no) |
PT (1) | PT100807A (no) |
WO (1) | WO1993003692A1 (no) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5679399A (en) | 1987-07-17 | 1997-10-21 | Bio Barrier, Inc. | Method of forming a membrane, especially a latex or polymer membrane, including multiple discrete layers |
US5549924A (en) | 1987-07-17 | 1996-08-27 | Robin Renee Thill Shlenker | Method of forming a membrane, especially a latex or polymer membrane, including a deactivating barrier and indicating layer |
AU6957594A (en) * | 1993-05-26 | 1994-12-20 | Becton Dickinson & Company | Patch, with system and apparatus for manufacture |
DE4341444C2 (de) * | 1993-12-04 | 1996-03-14 | Lohmann Therapie Syst Lts | Wirkstoffhaltiges Pflaster und Verfahren zu seiner Herstellung |
CH686928A5 (fr) * | 1993-12-17 | 1996-08-15 | Westonbridge Int Ltd | Pansement adhésif pour l'administration transdermique d'un médicament. |
US5635203A (en) * | 1994-09-29 | 1997-06-03 | Alza Corporation | Transdermal device having decreased delamination |
US5814031A (en) * | 1995-03-02 | 1998-09-29 | Mooney; Mark | Structured occllusive dressings |
WO1996032142A1 (en) * | 1995-04-12 | 1996-10-17 | Hopp Robert B | Skin patch for use in contact immunotherapy |
US5730721A (en) | 1996-01-25 | 1998-03-24 | Vesture Corporation | Medical applicator and method |
DE19814084B4 (de) * | 1998-03-30 | 2005-12-22 | Lts Lohmann Therapie-Systeme Ag | D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung |
US6337328B1 (en) | 1999-03-01 | 2002-01-08 | Sepracor, Inc. | Bupropion metabolites and methods of use |
DE10041478A1 (de) | 2000-08-24 | 2002-03-14 | Sanol Arznei Schwarz Gmbh | Neue pharmazeutische Zusammensetzung |
DE10234673B4 (de) * | 2002-07-30 | 2007-08-16 | Schwarz Pharma Ag | Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren |
US8246980B2 (en) * | 2002-07-30 | 2012-08-21 | Ucb Pharma Gmbh | Transdermal delivery system |
US8246979B2 (en) | 2002-07-30 | 2012-08-21 | Ucb Pharma Gmbh | Transdermal delivery system for the administration of rotigotine |
US8211462B2 (en) * | 2002-07-30 | 2012-07-03 | Ucb Pharma Gmbh | Hot-melt TTS for administering rotigotine |
EP1426049B1 (en) * | 2002-12-02 | 2005-05-18 | Schwarz Pharma Ag | Iontophoretic delivery of rotigotine for the treatment of Parkinson's disease |
DE10261696A1 (de) | 2002-12-30 | 2004-07-15 | Schwarz Pharma Ag | Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base |
EP1682211B1 (en) | 2003-10-27 | 2009-11-18 | Universität Basel | Transdermal drug delivery system |
US8252321B2 (en) | 2004-09-13 | 2012-08-28 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like |
US7780981B2 (en) * | 2004-09-13 | 2010-08-24 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery |
AU2006235565A1 (en) * | 2005-04-11 | 2006-10-19 | The Board Of Trustees Of The Leland Stanford Junior University | Multi-layer structure having a predetermined layer pattern including an agent |
WO2006127905A2 (en) | 2005-05-24 | 2006-11-30 | Chrono Therapeutics, Inc. | Portable drug delivery device |
US8287923B2 (en) * | 2005-06-10 | 2012-10-16 | Medical College Of Georgia Research Institute, Inc. | Compositions and methods for treating immune disorders |
US9446017B2 (en) | 2005-08-11 | 2016-09-20 | Augusta University Research Institute, Inc. | Compositions and methods for treating herpes simplex virus |
JP5234967B2 (ja) | 2006-02-27 | 2013-07-10 | エドワーズ ライフサイエンシーズ コーポレイション | 静脈内電流測定バイオセンサのための流束制限膜 |
BRPI0621655A2 (pt) * | 2006-05-08 | 2011-12-20 | Teikoku Seiyaku Kk | preparação para a absorção percutánea de uma droga antidemência básica |
US9114133B2 (en) | 2006-08-25 | 2015-08-25 | U.S. Dept. Of Veterans Affairs | Method of improving diastolic dysfunction |
EA020208B1 (ru) | 2007-07-10 | 2014-09-30 | Эджайл Терапьютикс, Инк. | Устройство доставки в кожу с изолирующим слоем in situ |
US20130017188A1 (en) | 2009-07-31 | 2013-01-17 | The Brigham And Women's Hospital, Inc. | Modulation of sgk1 expression in th17 cells to modulate th17-mediated immune responses |
CA2794565C (en) | 2010-04-08 | 2018-08-21 | Emory University | Substituted androst-4-ene diones |
WO2012129237A2 (en) | 2011-03-20 | 2012-09-27 | Trustees Of Boston University | Therapeutic agent for emphysema and copd |
EP2704726B1 (en) | 2011-05-04 | 2018-10-31 | Trustees of Boston University | Proton-motive force stimulation to potentiate aminoglycoside antibiotics against persistent bacteria |
WO2013003697A1 (en) | 2011-06-30 | 2013-01-03 | Trustees Of Boston University | Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1) |
EP2729148A4 (en) | 2011-07-06 | 2015-04-22 | Parkinson S Inst | COMPOSITIONS AND METHODS FOR TREATING SYMPTOMS IN PATIENTS WITH PARKINSON'S DISEASE |
EP2543370A1 (en) | 2011-07-06 | 2013-01-09 | Georgia Health Sciences University Research Institute, Inc. | Compositions and Methods for Treating Herpes Simplex Virus |
WO2013071049A1 (en) | 2011-11-10 | 2013-05-16 | Trustees Of Boston College | Gramicidin a mutants that function as antibiotics with improved solubility and reduced toxicity |
US10105487B2 (en) | 2013-01-24 | 2018-10-23 | Chrono Therapeutics Inc. | Optimized bio-synchronous bioactive agent delivery system |
US20150366890A1 (en) | 2013-02-25 | 2015-12-24 | Trustees Of Boston University | Compositions and methods for treating fungal infections |
WO2015027146A1 (en) | 2013-08-22 | 2015-02-26 | The General Hospital Corporation | Inhibitors of human 12/15-lipoxygenase |
WO2015031765A2 (en) | 2013-08-29 | 2015-03-05 | Trustees Of Boston University | Intermediate metabolism products to potentiate aminoglycoside antibiotics in bacterial infections |
CA2974324A1 (en) | 2015-01-28 | 2016-08-04 | Zita S. Netzel | Drug delivery methods and systems |
JP2018511127A (ja) | 2015-03-12 | 2018-04-19 | クロノ セラピューティクス インコーポレイテッドChrono Therapeutics Inc. | 渇望入力及び支援システム |
EP3303286B1 (en) | 2015-06-01 | 2023-10-04 | Cedars-Sinai Medical Center | Compounds that bind to rela of nf-kb for use in treating cancer |
AU2016298826A1 (en) | 2015-07-28 | 2018-02-15 | Vyome Therapeutics Limited | Antibacterial therapeutics and prophylactics |
WO2018129304A1 (en) | 2017-01-06 | 2018-07-12 | Chrono Therapeutics Inc. | Transdermal drug delivery devices and methods |
US11596779B2 (en) | 2018-05-29 | 2023-03-07 | Morningside Venture Investments Limited | Drug delivery methods and systems |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3598122A (en) * | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
US3797494A (en) * | 1969-04-01 | 1974-03-19 | Alza Corp | Bandage for the administration of drug by controlled metering through microporous materials |
US3598123A (en) * | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
US3742951A (en) * | 1971-08-09 | 1973-07-03 | Alza Corp | Bandage for controlled release of vasodilators |
CA1163561A (en) * | 1979-11-06 | 1984-03-13 | Cyril Boroda | Preparation containing nitroglycerine and optionally other medicaments and preparation thereof |
US4286592A (en) * | 1980-02-04 | 1981-09-01 | Alza Corporation | Therapeutic system for administering drugs to the skin |
IL61721A (en) * | 1980-12-16 | 1984-03-30 | Blank Izhak | Nitroglycerin preparations |
US4650484A (en) * | 1983-02-03 | 1987-03-17 | Alza Corporation | Method for treating ischemic conditions |
US4559222A (en) * | 1983-05-04 | 1985-12-17 | Alza Corporation | Matrix composition for transdermal therapeutic system |
AT387394B (de) * | 1983-06-03 | 1989-01-10 | Isovolta | Verfahren zur polykondensation von diphenolen und dicarbonsaeurehalogeniden |
JPS60225143A (ja) * | 1984-04-20 | 1985-11-09 | Konishiroku Photo Ind Co Ltd | ハロゲン化銀写真感光材料 |
US4786282A (en) * | 1985-02-26 | 1988-11-22 | Adria Laboratories | Bandage for the topical administration of controlled amounts of nitroglycerin ointment |
US4751087A (en) * | 1985-04-19 | 1988-06-14 | Riker Laboratories, Inc. | Transdermal nitroglycerin delivery system |
US4681584A (en) * | 1985-05-03 | 1987-07-21 | Alza Corporation | Transdermal delivery system for delivering nitroglycerin at high transdermal fluxes |
DE3518707A1 (de) * | 1985-05-24 | 1986-11-27 | Beiersdorf Ag, 2000 Hamburg | Nitro-pflaster |
JPS61293911A (ja) * | 1985-06-24 | 1986-12-24 | Teisan Seiyaku Kk | 徐放化製剤 |
US4655766A (en) * | 1985-08-01 | 1987-04-07 | Alza Corporation | Fluid imbibing pump with self-regulating skin patch |
DE3617158C2 (de) * | 1986-05-22 | 1994-10-06 | Lohmann Therapie Syst Lts | Transdermales Arzneimittel |
CA1272922A (en) * | 1986-06-03 | 1990-08-21 | Peter William Berry | Drug delivery device, its preparation and use |
US4917676A (en) * | 1986-11-20 | 1990-04-17 | Ciba-Geigy Corporation | User-activated transdermal therapeutic system |
US4956181A (en) * | 1987-05-08 | 1990-09-11 | Eastman Kodak | Nitrate therapy for angina pectoris |
US4849224A (en) * | 1987-11-12 | 1989-07-18 | Theratech Inc. | Device for administering an active agent to the skin or mucosa |
US5073539A (en) * | 1990-01-22 | 1991-12-17 | Ciba-Geigy Corporation | Transdermal administration of zwitterionic drugs |
US5273755A (en) * | 1991-08-23 | 1993-12-28 | Cygnus Therapeutic Systems | Transdermal drug delivery device using a polymer-filled microporous membrane to achieve delayed onset |
US5234690A (en) * | 1991-08-23 | 1993-08-10 | Cygnus Therapeutic Systems | Transdermal drug delivery device using an unfilled microporous membrane to achieve delayed onset |
-
1991
- 1991-08-23 US US07/748,935 patent/US5273756A/en not_active Expired - Lifetime
-
1992
- 1992-08-14 CA CA002115570A patent/CA2115570A1/en not_active Abandoned
- 1992-08-14 WO PCT/US1992/006839 patent/WO1993003692A1/en not_active Application Discontinuation
- 1992-08-14 JP JP5504461A patent/JPH06510043A/ja active Pending
- 1992-08-14 EP EP92919052A patent/EP0600023A4/en not_active Withdrawn
- 1992-08-14 AU AU25037/92A patent/AU670410B2/en not_active Ceased
- 1992-08-18 NZ NZ244000A patent/NZ244000A/en unknown
- 1992-08-24 PT PT100807A patent/PT100807A/pt not_active Application Discontinuation
-
1994
- 1994-02-21 NO NO940589A patent/NO940589L/no unknown
- 1994-02-23 FI FI940850A patent/FI940850A/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU670410B2 (en) | 1996-07-18 |
NZ244000A (en) | 1995-04-27 |
EP0600023A1 (en) | 1994-06-08 |
JPH06510043A (ja) | 1994-11-10 |
US5273756A (en) | 1993-12-28 |
PT100807A (pt) | 1994-05-31 |
AU2503792A (en) | 1993-03-16 |
WO1993003692A1 (en) | 1993-03-04 |
NO940589D0 (no) | 1994-02-21 |
FI940850A0 (fi) | 1994-02-23 |
EP0600023A4 (en) | 1995-06-14 |
CA2115570A1 (en) | 1993-03-04 |
FI940850A (fi) | 1994-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO940589L (no) | Transdermal medikamentavleveringsinnretning som anvender en membranbeskyttet mikroporös membran for å oppnå forsinket begynnelse | |
CA1252361A (en) | Transdermal delivery of highly ionized fat soluble drugs | |
DK0413487T3 (da) | Fremgangsmåde og indretning til transdermal indgivelse af dexmedetomidin | |
DK0889723T3 (da) | Transdermalt terapeutisk system med ringe tykkelse af administreringsareal og stor fleksibilitet samt fremgangsmåde til fremstilling heraf | |
ATE5563T1 (de) | Therapeutisches system zum zufuehren von arzneimitteln zur haut. | |
NO952907D0 (no) | Transdermalt terapeutisk system med galanthamin som virksom bestanddel | |
NO950051L (no) | Plaster for lavtsmeltende og/eller flyktige aktive bestanddeler | |
IL91123A0 (en) | Multilayer plaster | |
DE69916492D1 (de) | Pflaster zur transdermalen applikation von flüchtigen, flüssigen wirkstoffen | |
ATE396714T1 (de) | Transdermales therapeutisches system mit verbessertem langzeittragekomfort | |
HRP930991A2 (en) | Transdermal therapeutic system containing the active tance 17-beta-oestradiol and the process for the production eof | |
ID24266A (id) | Sistim terapetik transdermal yang mengandung bahan aktif basa skopolamin | |
DK0667774T3 (da) | Transdermalt, terapeutisk system til indgivelse af physostigmin genem huden og fremgangsmåde til dets fremstilling | |
NO924926L (no) | Transdermal administrering av buprenorfin |